Ligand validation:7HMK

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HMK_EDO_B_201	77%	88%	0.106	0.945	0.09	0.56	-	-	0	0	100%	1
7HMK_EDO_B_203	29%	99%	0.16	0.816	0.12	0.11	-	-	0	0	100%	1
9GTE_EDO_B_501	96%	88%	0.063	0.972	0.19	0.48	-	-	0	0	100%	1
7HMG_EDO_B_201	79%	92%	0.103	0.948	0.06	0.47	-	-	0	0	100%	1
7HM7_EDO_B_201	70%	93%	0.117	0.934	0.12	0.37	-	-	0	0	100%	1
7HO5_EDO_B_201	64%	89%	0.128	0.926	0.1	0.52	-	-	0	0	100%	1
7HMC_EDO_B_201	56%	88%	0.141	0.912	0.14	0.53	-	-	0	0	100%	1
4CQM_EDO_I_402	100%	83%	0.029	0.992	0.46	0.33	-	-	0	0	100%	1
7Y44_EDO_F_102	100%	65%	0.03	0.992	0.5	0.83	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
2NRL_EDO_A_301	100%	92%	0.036	0.99	0.44	0.09	-	-	0	0	100%	1
3QM5_EDO_A_203	100%	97%	0.038	0.992	0.27	0.05	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.